- Home
- ONMD vs AIFF Comparison
ONMD vs AIFF Comparison
Compare ONMD & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- AIFF
- Stock Information
- Founded
- ONMD 2006
- AIFF 2006
- Country
- ONMD United States
- AIFF Canada
- Employees
- ONMD N/A
- AIFF N/A
- Industry
- ONMD
- AIFF
- Sector
- ONMD
- AIFF
- Exchange
- ONMD Nasdaq
- AIFF NYSE
- Market Cap
- ONMD 32.5M
- AIFF 26.6M
- IPO Year
- ONMD N/A
- AIFF N/A
- Fundamental
- Price
- ONMD $1.37
- AIFF $3.49
- Analyst Decision
- ONMD
- AIFF
- Analyst Count
- ONMD 0
- AIFF 0
- Target Price
- ONMD N/A
- AIFF N/A
- AVG Volume (30 Days)
- ONMD 201.3K
- AIFF 7.2M
- Earning Date
- ONMD 12-17-2024
- AIFF 02-21-2025
- Dividend Yield
- ONMD N/A
- AIFF N/A
- EPS Growth
- ONMD N/A
- AIFF N/A
- EPS
- ONMD 0.01
- AIFF N/A
- Revenue
- ONMD $957,651.00
- AIFF $74,000.00
- Revenue This Year
- ONMD N/A
- AIFF N/A
- Revenue Next Year
- ONMD N/A
- AIFF N/A
- P/E Ratio
- ONMD $163.82
- AIFF N/A
- Revenue Growth
- ONMD 1.36
- AIFF N/A
- 52 Week Low
- ONMD $0.46
- AIFF $1.86
- 52 Week High
- ONMD $3.37
- AIFF $15.90
- Technical
- Relative Strength Index (RSI)
- ONMD 61.87
- AIFF 58.80
- Support Level
- ONMD $1.33
- AIFF $3.43
- Resistance Level
- ONMD $1.46
- AIFF $4.18
- Average True Range (ATR)
- ONMD 0.13
- AIFF 0.59
- MACD
- ONMD -0.01
- AIFF 0.15
- Stochastic Oscillator
- ONMD 73.47
- AIFF 41.37
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support better outcomes for people suffering from mental illnesses and cognitive disorders.